CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
- Status
- RECRUITING
- Phase
- N/A
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Thromboembolic Risk Assessment in Patients Admitted With Acute Medical Diseases to Conventional and At Home Hospitalization
- Status
- RECRUITING
- Phase
- N/A
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Medical Access Program for Patritumab Deruxtecan
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Basket Study for Oligo-metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
National Register of Actionable Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): Pilot Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A